| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,635 | 0,730 | 13:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 28.11. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 17.11. | ADVANCE ZINCTEK LIMITED: FDA Inspection Update | - | ASX | ||
| 14.11. | ADVANCE ZINCTEK LIMITED: Results of Meeting | 1 | ASX | ||
| 13.11. | ADVANCE ZINCTEK LIMITED: Chair's Presentation to Shareholders | - | ASX | ||
| 17.10. | ADVANCE ZINCTEK LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 02.10. | ADVANCE ZINCTEK LIMITED: Improvement of 26.83% in First Quarter Revenue - FY26 | 2 | ASX | ||
| ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
| 26.09. | ADVANCE ZINCTEK LIMITED: Statement Regarding US Pharmaceutical Tariffs | - | ASX | ||
| 03.09. | ADVANCE ZINCTEK LIMITED: Response to Rumours Re CHOICE Sunscreen Test Findings | 1 | ASX | ||
| 29.08. | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | 2 | ASX | ||
| 29.08. | ADVANCE ZINCTEK LIMITED: Appendix 4G | 1 | ASX | ||
| 29.08. | ADVANCE ZINCTEK LIMITED: Annual Report to shareholders | 1 | ASX | ||
| 29.08. | ADVANCE ZINCTEK LIMITED: Appendix 4E | 1 | ASX | ||
| 21.07. | ADVANCE ZINCTEK LIMITED: Response to ASX Price Query | 2 | ASX | ||
| 09.07. | ADVANCE ZINCTEK LIMITED: Update on Tariffs Announced by Trump Administration Today | 1 | ASX | ||
| 30.06. | ADVANCE ZINCTEK LIMITED: Update on $2.7 Million Profit Turnaround | 1 | ASX | ||
| 27.06. | ADVANCE ZINCTEK LIMITED: Application for quotation of securities - ANO | 1 | ASX | ||
| 26.06. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 24,950 | -2,35 % | Formycon schließt Partnerschaft mit MS Pharma | Mitteilung der Formycon AG: Formycon und MS Pharma schließen exklusive Kommerzialisierungspartnerschaft für den Keytruda-Biosimilar-Kandidaten FYB206 in der MENA-Region Die Formycon AG (FWB: FYB, Prime... ► Artikel lesen | |
| SOLESENCE | 2,050 | -5,53 % | SOLESENCE, INC. - 8-K, Current Report | ||
| GAUZY | 1,830 | -1,08 % | Gauzy Ltd. Raises $12 Million Investment to Advance Capital Objectives and Provides Update on Board Composition | TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has raised... ► Artikel lesen | |
| ONTO INNOVATION | 135,00 | -0,74 % | Onto Innovation Inc. (ONTO): A Bull Case Theory | ||
| VEECO INSTRUMENTS | 27,000 | -2,17 % | Veeco Instruments Inc.: Veeco's Laser Spike Annealing (LSA) System Selected by Leading Semiconductor Memory Company for Advanced DRAM Evaluation | ||
| NANOFORM FINLAND | 0,994 | +8,16 % | Nanoform Finland Oyj: Nanoform Q3 report: Momentum in kernels continues, commercial cGMP manufacturing license received, first near-term target for 2026 set | Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET
Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and... ► Artikel lesen | |
| KOPIN | 2,338 | +1,30 % | Kopin appoints new leadership to drive microdisplay technology roadmap | ||
| FENDX TECHNOLOGIES | 0,302 | -16,57 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| GOMSPACE | 1,480 | +1,37 % | GOMSPACE GROUP AB: GomSpace signs 1.2 MEUR contract with ESA for SECUSAT: A major step forward in secure space communications for a safer world | ||
| LAMPETIA | 0,090 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| ACACIA RESEARCH | 3,220 | -3,01 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| NVE | 58,00 | +3,57 % | Dividendenbekanntmachungen (03.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,1748 USD 0,1515 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
| NANOFOCUS | 1,810 | +0,56 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| RIBER | 3,230 | 0,00 % | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen | |
| NANOVIRICIDES | 0,970 | +11,49 % | NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles | SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen |